ACHV
Price
$2.38
Change
+$0.02 (+0.85%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
81.86M
10 days until earnings call
ATOS
Price
$0.74
Change
-$0.02 (-2.63%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
97.68M
21 days until earnings call
Ad is loading...

ACHV vs ATOS

Header iconACHV vs ATOS Comparison
Open Charts ACHV vs ATOSBanner chart's image
Achieve Life Sciences
Price$2.38
Change+$0.02 (+0.85%)
Volume$2.78K
Capitalization81.86M
Atossa Therapeutics
Price$0.74
Change-$0.02 (-2.63%)
Volume$2.91K
Capitalization97.68M
ACHV vs ATOS Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. ATOS commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and ATOS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (ACHV: $2.36 vs. ATOS: $0.76)
Brand notoriety: ACHV and ATOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 138% vs. ATOS: 62%
Market capitalization -- ACHV: $81.86M vs. ATOS: $97.68M
ACHV [@Biotechnology] is valued at $81.86M. ATOS’s [@Biotechnology] market capitalization is $97.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileATOS’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ATOS’s FA Score: 0 green, 5 red.
According to our system of comparison, ATOS is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while ATOS’s TA Score has 5 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 3 bearish.
  • ATOS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than ATOS.

Price Growth

ACHV (@Biotechnology) experienced а +18.59% price change this week, while ATOS (@Biotechnology) price change was +21.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.74%. For the same industry, the average monthly price growth was +0.71%, and the average quarterly price growth was -9.55%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 07, 2025.

ATOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+10.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($97.7M) has a higher market cap than ACHV($81.9M). ATOS YTD gains are higher at: -19.903 vs. ACHV (-32.955). ATOS has higher annual earnings (EBITDA): -29.46M vs. ACHV (-37.42M). ATOS has more cash in the bank: 74.8M vs. ACHV (34.3M). ATOS has less debt than ACHV: ATOS (0) vs ACHV (9.96M). ACHV (0) and ATOS (0) have equivalent revenues.
ACHVATOSACHV / ATOS
Capitalization81.9M97.7M84%
EBITDA-37.42M-29.46M127%
Gain YTD-32.955-19.903166%
P/E RatioN/AN/A-
Revenue00-
Total Cash34.3M74.8M46%
Total Debt9.96M0-
FUNDAMENTALS RATINGS
ACHV vs ATOS: Fundamental Ratings
ACHV
ATOS
OUTLOOK RATING
1..100
6311
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
9064
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (50) in the Biotechnology industry is in the same range as ATOS (50) in the Medical Specialties industry. This means that ACHV’s stock grew similarly to ATOS’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATOS (100) in the Medical Specialties industry. This means that ACHV’s stock grew similarly to ATOS’s over the last 12 months.

ATOS's SMR Rating (93) in the Medical Specialties industry is in the same range as ACHV (99) in the Biotechnology industry. This means that ATOS’s stock grew similarly to ACHV’s over the last 12 months.

ATOS's Price Growth Rating (64) in the Medical Specialties industry is in the same range as ACHV (90) in the Biotechnology industry. This means that ATOS’s stock grew similarly to ACHV’s over the last 12 months.

ATOS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as ACHV (100) in the Biotechnology industry. This means that ATOS’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVATOS
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGXEF0.06N/A
+7.69%
CGX Energy Inc.
ELEZY14.740.31
+2.15%
Endesa S.A.
RNMBY315.161.33
+0.42%
Rheinmetall AG
MARK0.05N/A
-0.84%
Remark Holdings, Inc.
OPHLY3.72-0.13
-3.50%
Ono Pharmaceutical Co., Ltd.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ERAS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.67%
ERAS - ACHV
41%
Loosely correlated
-0.71%
ABOS - ACHV
40%
Loosely correlated
-1.82%
ATOS - ACHV
40%
Loosely correlated
+3.22%
ELVN - ACHV
39%
Loosely correlated
-0.49%
AXSM - ACHV
38%
Loosely correlated
+0.82%
More

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
+3.22%
ABOS - ATOS
56%
Loosely correlated
-1.82%
GBIO - ATOS
50%
Loosely correlated
+1.55%
ERAS - ATOS
49%
Loosely correlated
-0.71%
ABCL - ATOS
49%
Loosely correlated
-1.15%
AKBA - ATOS
45%
Loosely correlated
+4.39%
More